CDU ADMINISTRATIVE CORE Each partnering institution, CDU and UCLA has established an Administrative Core which will continue to ensure that all research projects, cores, services and faculty receive the necessary administrative support and coordination for success in the areas of cancer research, education, and outreach. The Administrative Core will work hand-in-hand with the Planning and Evaluation Core to ensure effective planning, communication and continuous evaluation of partnership activities. The CDU Administrative Core for the Partnership will be directed by the CDU PI, Dr. Jay Vadgama, who brings a strong translational cancer health disparities research background, mentorship track record to the team, and strong research management skills and experience to the Center. He will work collaboratively with the UCLA PI and UCLA Administrative Core Director, Dr. Robin Farias-Eisner. They have balancing strengths and have worked together very well as colleagues for over 9 years, and jointly as PIs of the U54 for the past 2-3 years. Together they have been successful at jointly recruiting U54 faculty; participating in community activities and conferences; and partnering for the evaluation of short-term progress and research activities of the pilot investigators. As PI, Dr. Vadgama will direct Program Managers and Finance Managers in day-to-day administrative support, coordination, and logistical services needed to make the partnership function effectively. This includes organizing communication across the Partnership, meetings, as well as documenting the results of activities and coordinating and supporting the Program Steering Committee (PSC) and Internal Advisory Committee (IAC). Dr. Vadgama has implemented systems at CDU to ensure the administrative integration of the partnership. These include communication through structured meetings, e-mail correspondence, and tracking mechanisms of partnership activities pertaining to cancer research, research education and outreach. The Core serves as the hub for documentation, tracking, and integration of facilities, faculty, resources, and projects within the Partnership. In addition to these responsibilities, the Administrative Core also oversees recruitment for the Center and ensures that recruitment objectives are met. Recruitment will be of faculty who can strengthen partnership capabilities in critical priority areas identified by the partnership leadership, IAC and PSC. For example: cancer survivorship, clinical trials, and cancer genomics targeted toward precision medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143931-07
Application #
9152257
Study Section
Special Emphasis Panel (ZCA1-PCRB-C)
Program Officer
Ojeifo, John O
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
7
Fiscal Year
2016
Total Cost
$296,693
Indirect Cost
$89,938
Name
Charles R. Drew University of Medicine & Science
Department
Type
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Boonyaratanakornkit, Viroj; Hamilton, Nalo; Márquez-Garbán, Diana C et al. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol 466:51-72
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Maxwell, Annette E; Young, Sandra; Moe, Emily et al. (2018) Understanding Factors that Influence Health Care Utilization Among Mixtec and Zapotec Women in a Farmworker Community in California. J Community Health 43:356-365
Maxwell, Annette E; Castillo, Laura; Arce, Anthony A et al. (2018) Eating Veggies Is Fun! An Implementation Pilot Study in Partnership With a YMCA in South Los Angeles. Prev Chronic Dis 15:E132
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Dong, Yunzhou; Wu, Yong; Cui, Mei-Zhen et al. (2017) Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21. Mediators Inflamm 2017:2754756
Zhang, Yu-Yao; Li, Chao; Yao, Gao-Feng et al. (2017) Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ER?/HGF/Met Pathway. Diabetes 66:1535-1547
Kiyohara, M H; Dillard, C; Tsui, J et al. (2017) EMP2 is a novel therapeutic target for endometrial cancer stem cells. Oncogene 36:5793-5807
McGhee, Eva; Harper, Hill; Ume, Adaku et al. (2017) Elimination of Cancer Health Disparities through the Acceleration of HPV Vaccines and Vaccinations: A Simplified Version of the President's Cancer Panel Report on HPV Vaccinations. J Vaccines Vaccin 8:
Wu, Yanyuan; Sarkissyan, Marianna; Clayton, Sheilah et al. (2017) Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women. Cancers (Basel) 9:

Showing the most recent 10 out of 90 publications